Findings from the DUMA program: internet access, and frequency and nature of use among police detainees

Examining access to and the extent of engagement with the Internet in illicit drug-using populations may provide an indication of the extent to which the online illicit drug market is usurping the physical illicit drug market, according to this report. Summary The advent of the Internet has created opportunities for the global exchange of information and purchase of goods and services. However, it has also facilitated the creation of online illicit drug markets and forums in which drug-related information can be exchanged between users. Bruno, Poesiat & Matthews (2013) reported that illicit drug-specific search terms (such as cocaine, ecstasy, hallucinogens and high) were used, on average, 39,700 times per month in the Google search engine in Australia. Examining access to and the extent of engagement with the Internet in illicit drug-using populations may provide an indication of the extent to which the online illicit drug market is usurping the physical illicit drug market. In 2006, Cunningham, Selby, Kypri & Humphreys examined Internet access in a sample of smokers, drinkers and illicit drug users (n=2,584) derived from the general population in Canada, through a random digit dialling technique. Restricting the findings to illicit drug users, 77 percent of cannabis users and 75 percent of cocaine users reported having Internet access. It would be anticipated that current Internet access rates would be considerably higher in all subgroups of the population, including illicit drug users, than those recorded in 2006

Findings from the DUMA program: drink and drug driving among police detainees

This paper finds that detainees do perceive a risk related to drink and drug driving, in terms of impairment in driving ability and potential detection by police. These conditions are likely to result in deterrence from drink and drug driving for some detainees. Introduction In Australia, random breath testing (RBT) was introduced in the mid-1970s to detect drivers under the influence of alcohol. This resulted in a reduction in fatal crashes and alcohol-related traffic accidents across Australia. The success of RBT can be explained through the classic deterrence doctrine, which suggests that decision-making is influenced by the perception of whether the benefits of the crime outweigh the risks of being caught. The introduction of RBT arguably increased the perceived and real risk of being caught, which positively influenced individuals’ decisions to refrain from driving while intoxicated. Following the successful implementation of RBT, between 2004 (in Victoria) and 2011 (in the Australian Capital Territory), random roadside drug testing (RRDT) was introduced across Australia. The aim of RRDT was to deter drug driving, decreasing both the prevalence of drug driving and the associated harms. In 2013, data from the Australian Institute of Health and Welfare (AIHW) indicated that drug driving and drink driving had been engaged in by more than one in 10 Australians (16% and 12% respectively) surveyed during the previous 12 months. Rates of drug driving are even higher in populations where illicit drug use is common, such as among police detainees, where 65 percent of detainees surveyed reported driving while under the influence of alcohol and/or drugs in the previous 12 months. Examining perceptions of risk of drug driving, in terms of both being caught and legitimacy (perceptions of impairment to driving ability), will identify whether the preconditions exist to support drug driving deterrence through RRDT

Re-curating Testimony: Pedagogy for “Self-Aware” Witnessing

This paper will present the pedagogical approaches and initial outcomes from our experimental seminar at Concordia University titled “Curating Difficult Knowledge: Engaging with the aftermath of violence through public displays, memorials, and sites of conscience.” In this seminar, we sought to engage students in both critical examination and creative production around the question of what it means to “learn from the past” as global violence continues, based on a series of assignments designed to (1) bring them into deep engagement with survivor testimony while highlighting the numerous factors mediating this encounter; and (2) produce public displays based on this testimony that highlight these factors. The goal was for students to both learn about and apply their knowledge by actually attempting the hard work of representation at a critical historical juncture first hand. The emergent pedagogical insights will explore the many ways that ever-larger circles of people, removed in terms of community, generation, experience, are being asked to relate to Holocaust testimonies existing apart from their tellers. We will draw from our experience in critical museology, working with survivor testimony, and our respective attempts to develop new methodologies, pedagogy, and theory for confronting these difficult dilemmas. Stories of suffering are generally approached in the public realm with the sense that they are difficult because they contain subject matter that is painful, tragic, or gruesome. Less public attention is typically paid to the problems inherent in their transmission: that they are inevitably mediated, perspectival, and often contested. Our analysis of the process and final products produced in this course highlight the social lives of testimony and the broader work of memory in ethnographic terms, as it is concretely deployed in sites of embodied social practice. We continually remind students about social and cultural difference, power and perspective, and that in a global age, one cannot presumed a unitary “public” who will predictably consider, sympathize, or identify with Holocaust-related materials

The Lantern Vol. 10, No. 3, May 1942

• Isn\u27t This Fine Weather? • Girls\u27 Rules Through Twenty Years • Lost: Imagination--Gained: Sanitation • Ursinus During the First World War • Inspirations From a Concert Hall • Brother Jones • The Sea and Cloud and Sky--No More • Literary Prattle • War and Memories • Springhttps://digitalcommons.ursinus.edu/lantern/1027/thumbnail.jp

Surviving streptococcal toxic shock syndrome: a case report

Streptococcal toxic shock syndrome and associated myositis caused by group A beta-hemolytic streptococcus pyogenes generally have a poor outcome despite aggressive operative treatment. Frequently the diagnosis is missed initially as the clinical features are non-specific. The progression to a toxic state is rapid and unless definitive treatment measures are initiated early, the end result can be catastrophic. We report a previously healthy patient who had features of toxic shock syndrome due to alpha haemolytic (viridans) streptococcus mitis which was treated successfully with antibiotics, aggressive intensive care support including the use of a 'sepsis care bundle', monitoring and continuous multidisciplinary review. Life and limb threatening emergencies due to streptococcus mitis in an immune-competent person are rare and to our knowledge, have not previously been described in the English scientific literature. Successful outcome is possible provided a high degree of suspicion is maintained and the patient is intensively monitored

Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes.

OBJECTIVES: To estimate the lifetime risk, prevalence, incidence, and mortality of the principal clinical syndromes associated with frontotemporal lobar degeneration (FTLD) using revised diagnostic criteria and including intermediate clinical phenotypes. METHODS: Multisource referral over 2 years to identify all diagnosed or suspected cases of frontotemporal dementia (FTD), progressive supranuclear palsy (PSP), or corticobasal syndrome (CBS) in 2 UK counties (population 1.69 million). Diagnostic confirmation used current consensus diagnostic criteria after interview and reexamination. Results were adjusted to the 2013 European standard population. RESULTS: The prevalence of FTD, PSP, and CBS was 10.8/100,000. The incidence and mortality were very similar, at 1.61/100,000 and 1.56/100,000 person-years, respectively. The estimated lifetime risk is 1 in 742. Survival following diagnosis varied widely: from PSP 2.9 years to semantic variant FTD 9.1 years. Age-adjusted prevalence peaked between 65 and 69 years at 42.6/100,000: the age-adjusted prevalence for persons older than 65 years is double the prevalence for those between 40 and 64 years. Fifteen percent of those screened had a relevant genetic mutation. CONCLUSIONS: Key features of this study include the revised diagnostic criteria with improved specificity and sensitivity, an unrestricted age range, and simultaneous assessment of multiple FTLD syndromes. The prevalence of FTD, PSP, and CBS increases beyond 65 years, with frequent genetic causes. The time from onset to diagnosis and from diagnosis to death varies widely among syndromes, emphasizing the challenge and importance of accurate and timely diagnosis. A high index of suspicion for FTLD syndromes is required by clinicians, even for older patients.This study was funded by the NIHR Cambridge Dementia Biomedical Research Centre and Biomedical Research Unit in Dementia; the Wellcome Trust (103838), the PSP Association; Alzheimer Research UK; The Evelyn Trust.This is the final version of the article. It first appeared from Wolters Kluwer via http://dx.doi.org/10.​1212/​WNL.​000000000000263

The use of complementary and alternative medicines among patients with locally advanced breast cancer – a descriptive study

BACKGROUND: Complementary and alternative medicine (CAM) use is common among cancer patients. This paper reviews the use of CAM in a series of patients with locally advanced breast cancer (LABC). METHODS: Women with LABC attending a specialist clinic at a single Canadian cancer centre were identified and approached. Participants completed a self-administered survey regarding CAM usage, beliefs associated with CAM usage, views of their risks of developing recurrent cancer and of dying of breast cancer. Responses were scored and compared between CAM users and non-users. RESULTS: Thirty-six patients were approached, 32 completed the questionnaire (response rate 89%). Forty-seven percent of LABC patients were identified as CAM users. CAM users were more likely to be younger, married, in a higher socioeconomic class and of Asian ethnicity than non-users. CAM users were likely to use multiple modalities simultaneously (median 4) with vitamins being the most popular (60%). Motivation for CAM therapy was described as, "assisting their body to heal" (75%), to 'boost the immune system' (56%) and to "give a feeling of control with respect to their treatment" (56%). CAM therapy was used concurrently with conventional treatment in 88% of cases, however, 12% of patients felt that CAM could replace their conventional therapy. Psychological evaluation suggests CAM users perceived their risk of dying of breast cancer was similar to that of the non-Cam group (33% vs. 35%), however the CAM group had less severe anxiety and depression. CONCLUSION: The motivation, objectives and benefits of CAM therapy in a selected population of women with LABC are similar to those reported for women diagnosed with early stage breast cancer. CAM users display less anxiety and depression and are less likely to believe they will die of their breast cancer. However the actual benefit to overall and disease free survival has yet to be demonstrated, as well as the possible interactions with conventional therapy. Consequently more research is needed in this ever-growing field